Does Chronic Use of High Dose Proton Pump Inhibitors Increase Risk for Pancreatic Cancer?

Matthew A HuberSandeep NadellaHong CaoBhaskar KallakuryRobin D TuckerMartha D GayNarayan ShivapurkarElijah F EdmondsonYuanzhen YueWenyu DouHong-Bin FangNicholas Osborne

Published in: Pancreas (2023)

This investigation revealed in both murine models and human subjects, PPI use is correlated with a risk for development of pancreatic cancer.

Keyphrases

high dose
endothelial cells
low dose
single cell
small molecule
stem cell transplantation
pluripotent stem cells
drug induced
protein protein